E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53

Mol Cancer Res. 2003 Apr;1(6):438-44.

Abstract

E2FBP1/DRIL1 is an AT-rich interaction domain DNA-binding protein and is ubiquitously expressed in various tissues. It has been shown that Bright, the mouse orthologue of E2FBP1/DRIL1, exhibits sequence-specific DNA binding and regulates immunoglobulin transcription. Here we show a novel connection between E2FBP1/DRIL1 and the p53 tumor suppressor, a key regulator of growth arrest or apoptosis in response to cellular stress. We found a putative p53-binding site, which specifically responded to p53, in the second intron of the E2FBP1/DRIL1 gene. E2FBP1/DRIL1was induced by p53 and up-regulated following DNA damage caused by UV radiation or doxorubicin treatment in a manner dependent on endogenous p53. The ectopic expression of E2FBP1/DRIL1 induced growth arrest in U2OS cells expressing normal p53, but not Saos-2 cells lacking p53. These results suggest that E2FBP1/DRIL1 may play a role in growth suppression mediated by p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AT Rich Sequence / genetics*
  • Base Sequence
  • Cell Division
  • Cell Line, Tumor
  • Cyclin D1 / metabolism
  • DNA Damage
  • DNA-Binding Proteins / chemistry
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Introns / genetics
  • Molecular Sequence Data
  • Oncogenes / genetics*
  • Protein Binding
  • Protein Structure, Tertiary
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Trans-Activators*
  • Transcription Factors
  • Transcription, Genetic / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • ARID3A protein, human
  • DNA-Binding Proteins
  • RNA, Messenger
  • Trans-Activators
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Cyclin D1